Search research articles
Contact Us
Filters
Showing results (351-360 of 361) with videos related to
Page
of 37
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2019
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
Stephen M Ansell, Monique C Minnema, Peter Johnson, et al.
Vaccines
|
January 21, 2023
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A Rabaan, Mahmoud M Al Fawarah, et al.
BMJ Open
|
August 11, 2025
Pragmatic, multicentre, factorial, randomised controlled trial of sepsis electronic prompting for timely intervention and care (SEPTIC trial): a protocol
Benjamin L Ranard, Min Qian, Matthew J Cummings, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma
Ravi Vij, Shaji Kumar, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 14, 2013
Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma
Luciano J Costa, Mei-Jie Zhang, Xiaobo Zhong, et al.
Leukemia & Lymphoma
|
October 13, 2011
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant
Stefan O Ciurea, Rima M Saliba, Nelson Hamerschlak, et al.
Journal of Infection and Public Health
|
October 15, 2023
An updated review on pathogenic coronaviruses (CoVs) amid the emergence of SARS-CoV-2 variants: A look into the repercussions and possible solutions
Ali A Rabaan, Maha Fahad Alenazy, Ahmad A Alshehri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 18, 2013
Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma
Ayman Saad, Anuj Mahindra, Mei-Jie Zhang, et al.
The New England Journal of Medicine
|
July 1, 2026
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
Toni K Choueiri, Robert J Motzer, Jose A Karam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 7, 2016
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis
Emma C Scott, Parameswaran Hari, Manish Sharma, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 361) with videos related to
Sort By:
Page
of 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2019
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
Stephen M Ansell, Monique C Minnema, Peter Johnson, et al.
Vaccines
|
January 21, 2023
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A Rabaan, Mahmoud M Al Fawarah, et al.
BMJ Open
|
August 11, 2025
Pragmatic, multicentre, factorial, randomised controlled trial of sepsis electronic prompting for timely intervention and care (SEPTIC trial): a protocol
Benjamin L Ranard, Min Qian, Matthew J Cummings, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma
Ravi Vij, Shaji Kumar, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 14, 2013
Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma
Luciano J Costa, Mei-Jie Zhang, Xiaobo Zhong, et al.
Leukemia & Lymphoma
|
October 13, 2011
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant
Stefan O Ciurea, Rima M Saliba, Nelson Hamerschlak, et al.
Journal of Infection and Public Health
|
October 15, 2023
An updated review on pathogenic coronaviruses (CoVs) amid the emergence of SARS-CoV-2 variants: A look into the repercussions and possible solutions
Ali A Rabaan, Maha Fahad Alenazy, Ahmad A Alshehri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 18, 2013
Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma
Ayman Saad, Anuj Mahindra, Mei-Jie Zhang, et al.
The New England Journal of Medicine
|
July 1, 2026
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
Toni K Choueiri, Robert J Motzer, Jose A Karam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 7, 2016
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis
Emma C Scott, Parameswaran Hari, Manish Sharma, et al.
Page
of 37